BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 19525966)

  • 21. Southwestern Internal Medicine Conference: clinical use of hematopoietic growth factors.
    Fleischman RA
    Am J Med Sci; 1993 Apr; 305(4):248-73. PubMed ID: 7682752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transforming growth factor-beta trans-modulates the expression of colony stimulating factor receptors on murine hematopoietic progenitor cell lines.
    Jacobsen SE; Ruscetti FW; Dubois CM; Lee J; Boone TC; Keller JR
    Blood; 1991 Apr; 77(8):1706-16. PubMed ID: 1707695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of granulocyte-macrophage colony-stimulating factor in Philadelphia (Ph1)-positive acute lymphoblastic leukemia: studies on two newly established Ph1-positive acute lymphoblastic leukemia cell lines (Z-119 and Z-181).
    Estrov Z; Talpaz M; Zipf TF; Kantarjian HM; Ku S; Ouspenskaia MV; Hirsch-Ginsberg C; Huh Y; Yee G; Kurzrock R
    J Cell Physiol; 1996 Mar; 166(3):618-30. PubMed ID: 8600166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The requirement for granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in leukocyte-mediated immune glomerular injury.
    Kitching AR; Ru Huang X; Turner AL; Tipping PG; Dunn AR; Holdsworth SR
    J Am Soc Nephrol; 2002 Feb; 13(2):350-358. PubMed ID: 11805162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase I/II study of combined granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor administration for the mobilization of hematopoietic progenitor cells.
    Winter JN; Lazarus HM; Rademaker A; Villa M; Mangan C; Tallman M; Jahnke L; Gordon L; Newman S; Byrd K; Cooper BW; Horvath N; Crum E; Stadtmauer EA; Conklin E; Bauman A; Martin J; Goolsby C; Gerson SL; Bender J; O'Gorman M
    J Clin Oncol; 1996 Jan; 14(1):277-86. PubMed ID: 8558209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression and function of colony-stimulating factors and their receptors in human prostate carcinoma cell lines.
    Savarese DM; Valinski H; Quesenberry P; Savarese T
    Prostate; 1998 Feb; 34(2):80-91. PubMed ID: 9465939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A role for G-CSF and GM-CSF in nonmyeloid cancers.
    Aliper AM; Frieden-Korovkina VP; Buzdin A; Roumiantsev SA; Zhavoronkov A
    Cancer Med; 2014 Aug; 3(4):737-46. PubMed ID: 24692240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent developments in the cell biology of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor: activities on endothelial cells.
    Bussolino F; Colotta F; Bocchietto E; Guglielmetti A; Mantovani A
    Int J Clin Lab Res; 1993; 23(1):8-12. PubMed ID: 7682862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. G-CSF and GM-CSF concentrations and receptor expression in peripheral blood leukemic cells from patients with chronic myelogenous leukemia.
    Lee J; Kim Y; Lim J; Kim M; Han K
    Ann Clin Lab Sci; 2008; 38(4):331-7. PubMed ID: 18988925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flt3 ligand synergizes with granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor to mobilize hematopoietic progenitor cells into the peripheral blood of mice.
    Brasel K; McKenna HJ; Charrier K; Morrissey PJ; Williams DE; Lyman SD
    Blood; 1997 Nov; 90(9):3781-8. PubMed ID: 9345066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Granulocyte/macrophage colony-stimulating factor and accessory cells modulate radioprotection by purified hematopoietic cells.
    Katsumoto TR; Duda J; Kim A; Wardak Z; Dranoff G; Clapp DW; Shannon K
    J Exp Med; 2005 Mar; 201(6):853-8. PubMed ID: 15781578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of effect of granulocyte-macrophage and granulocyte colony-stimulating factors on cultured human endothelial cells.
    Yong K; Cohen H; Khwaja A; Jones HM; Linch DC
    Blood; 1991 Apr; 77(8):1675-80. PubMed ID: 1707693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term marrow reconstitutive ability of autologous grafts in lymphoma patients using peripheral blood mobilized with granulocyte colony-stimulating factor or granulocyte-macrophage colony-stimulating factor compared to bone marrow.
    Benboubker L; Cartron G; Roingeard F; Delain M; Degenne M; Linassier C; Hérault O; Truglio D; Bout M; Petit A; Brémond JL; Desbois I; Colombat P; Binet C; Domenech J
    Exp Hematol; 2003 Jan; 31(1):89-97. PubMed ID: 12543111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improvement in sensory function via granulocyte-macrophage colony-stimulating factor in rat spinal cord injury models.
    Kim JY; Oh CH; Huang X; Kim MH; Yoon SH; Kim KH; Park H; Park HC; Park SR; Choi BH
    J Neurosurg Spine; 2013 Jan; 18(1):69-75. PubMed ID: 23101949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclooxygenase-2 inhibitor NS-398 suppresses cell growth and constitutive production of granulocyte-colony stimulating factor and granulocyte macrophage-colony stimulating factor in lung cancer cells.
    Nakata H; Uemura Y; Kobayashi M; Harada R; Taguchi H
    Cancer Sci; 2003 Feb; 94(2):173-80. PubMed ID: 12708493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A neuroprotective function for the hematopoietic protein granulocyte-macrophage colony stimulating factor (GM-CSF).
    Schäbitz WR; Krüger C; Pitzer C; Weber D; Laage R; Gassler N; Aronowski J; Mier W; Kirsch F; Dittgen T; Bach A; Sommer C; Schneider A
    J Cereb Blood Flow Metab; 2008 Jan; 28(1):29-43. PubMed ID: 17457367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional analysis of mature hematopoietic cells from mice lacking the betac chain of the granulocyte-macrophage colony-stimulating factor receptor.
    Scott CL; Hughes DA; Cary D; Nicola NA; Begley CG; Robb L
    Blood; 1998 Dec; 92(11):4119-27. PubMed ID: 9834217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hematopoietic recovery following high-dose combined alkylating-agent chemotherapy and autologous bone marrow support in patients in phase-I clinical trials of colony-stimulating factors: G-CSF, GM-CSF, IL-1, IL-2, M-CSF.
    Laughlin MJ; Kirkpatrick G; Sabiston N; Peters W; Kurtzberg J
    Ann Hematol; 1993 Dec; 67(6):267-76. PubMed ID: 7506580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human granulocyte-macrophage colony-stimulating factor (hGM-CSF)-dependent in vitro and in vivo proliferation and differentiation of all hematopoietic progenitor cells in hGM-CSF receptor transgenic mice.
    Nishijima I; Watanabe S; Nakahata T; Arai K
    J Allergy Clin Immunol; 1997 Dec; 100(6 Pt 2):S79-86. PubMed ID: 9440551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Granulocyte colony-stimulating factor (G-CSF) and granulocyte macrophage colony-stimulating factor (GM-CSF) in Behçet's disease.
    Takahama H; Itoh R; Inoue-Komatsu C; Furusawa S; Takahashi H; Mizoguchi M
    J Dermatol; 1994 Aug; 21(8):546-52. PubMed ID: 7525676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.